Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MOLN compared with KURA: revenue, margins and what each company keeps, and the suppliers and customers both name
MOLN
Molecular Partners AG
Change
Mkt cap
Revenue
Revenue
KURA
Kura Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MOLN
Molecular Partners AG
vs
KURA
Kura Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
MOLN: latest quarter not drawable. KURA: latest quarter is a loss; flow not drawable.
Method
›
MOLN
Molecular Partners AG
Change
3.98
▲
+14.36%
· post 3.17
· delayed
Mkt cap
$144.5M
Revenue
—
Revenue
—
KURA
Kura Oncology, Inc.
Change
9.86
▲
+0.72%
· post 9.86
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$870.9M
Revenue
$21M
Q2 FY26
Revenue
$67M
FY25
vs
Compare
After hours
Nov 3 '26
delayed
MOLN
Molecular Partners AG
vs
KURA
Kura Oncology, Inc.
3.98
▲
+14.36%
post 3.17
delayed
Price
9.86
▲
+0.72%
post 9.86
delayed
$144.5M
Mkt cap
$870.9M
—
Revenue
$21M
Q2 FY26
—
Revenue
$67M
FY25
Change
Change
MOLN
3.98
▲
+14.36%
vs
KURA
9.86
▲
+0.72%
After hours
Nov 3 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MOLN
1
—
Orano Med
unlisted
supplier
Shared
0
No shared counterparties.
Only KURA
2
BMY
Mirati Therapeutics, Inc. (Bristol Myers Squibb)
supplier
—
Kyowa Kirin
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MOLN, solid
KURA, dashed